ENDOMETRIOID CARCINOMA

Clinical trials for ENDOMETRIOID CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIOID CARCINOMA trials appear

Sign up with your email to follow new studies for ENDOMETRIOID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

Can immunotherapy plus hormones spare the womb in early endometrial cancer?

Disease control Recruiting now

This trial is investigating whether combining an immunotherapy drug (a PD-1 inhibitor like sintilimab or pembrolizumab) with progesterone therapy can help young women with early-stage, mismatch repair-deficient (MMRd) endometrial cancer achieve complete remission while preserving…

Matched conditions: ENDOMETRIOID CARCINOMA

Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control

Last updated Aug 12, 2026 00:00 UTC

ENDOMETRIOID CARCINOMA

Get alerted when new ENDOMETRIOID CARCINOMA trials appear

Can immunotherapy plus hormones spare the womb in early endometrial cancer?